Defects in mitochondrial DNA replication and human disease

References

• Akman HO, Dorado B, López LC, García-Cazorla A, Vilà MR, Tanabe LM, Dauer WT, Bonilla E, Tanji K, Hirano M. 2008. Thymidine kinase 2 (H126N) knockin mice show the essential role of balanced deoxynucleotide pools for mitochondrial DNA maintenance. Hum Mol Genet 17:2433–2440.
   PubMed Web of Science ®Google Scholar
• Alberio S, Mineri R, Tiranti V, Zeviani M. 2007. Depletion of mtDNA: syndromes and genes. Mitochondrion 7:6–12.
   PubMedGoogle Scholar
• Baruffini E, Ferrero I, Foury F. 2007. Mitochondrial DNA defects in Saccharomyces cerevisiae caused by functional interactions between DNA polymerase gamma mutations associated with disease in human. Biochim Biophys Acta 1772:1225–1235.
   PubMedGoogle Scholar
• Baruffini E, Horvath R, Dallabona C, Czermin B, Lamantea E, Bindoff L, Invernizzi F, Ferrero I, Zeviani M, Lodi T. 2011. Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model. Mitochondrion 11:182–190.
   PubMedGoogle Scholar
• Baruffini E, Lodi T, Dallabona C, Puglisi A, Zeviani M, Ferrero I. 2006. Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. Hum Mol Genet 15:2846–2855.
   PubMedGoogle Scholar
• Blakely E, He L, Gardner JL, Hudson G, Walter J, Hughes I, Turnbull DM, Taylor RW. 2008. Novel mutations in the TK2 gene associated with fatal mitochondrial DNA depletion myopathy. Neuromuscul Disord 18:557–560.
   PubMedGoogle Scholar
• Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, Chrétien D, de Lonlay P, Paquis-Flucklinger V, Arakawa H, Nakamura Y, Munnich A, Rötig A. 2007. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39:776–780.
   PubMed Web of Science ®Google Scholar
• Carrozzo R, Bornstein B, Lucioli S, Campos Y, de la Pena P, Petit N, Dionisi-Vici C, Vilarinho L, Rizza T, Bertini E, Garesse R, Santorelli FM, Arenas J. 2003. Mutation analysis in 16 patients with mtDNA depletion. Hum Mutat 21:453–454.
   PubMed Web of Science ®Google Scholar
• Chan SS, Copeland WC. 2009. DNA polymerase gamma and mitochondrial disease: understanding the consequence of POLG mutations. Biochim Biophys Acta 1787:312–319.
   PubMed Web of Science ®Google Scholar
• Chan SS, Longley MJ, Copeland WC. 2005a. The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit. J Biol Chem 280:31341–31346.
   PubMed Web of Science ®Google Scholar
• Chan SS, Longley MJ, Copeland WC. 2006. Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders. Hum Mol Genet 15:3473–3483.
   PubMed Web of Science ®Google Scholar
• Chan SS, Longley MJ, Naviaux RK, Copeland WC. 2005b. Mono-allelic POLG expression resulting from nonsense-mediated decay and alternative splicing in a patient with Alpers syndrome. DNA Repair (Amst) 4:1381–1389.
   PubMedGoogle Scholar
• Cohen BH, Chinnery PF, Copeland WC. 2010 POLG-Related Disorders. GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Copyright, University of Washington, Seattle, 1997-2010. http://www.genetests.org
   Google Scholar
• Cohen BH, Naviaux RK. 2010. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 51:364–373.
   PubMedGoogle Scholar
• Collins J, Bove KE, Dimmock D, Morehart P, Wong LJ, Wong B. 2009. Progressive myofiber loss with extensive fibro-fatty replacement in a child with mitochondrial DNA depletion syndrome and novel thymidine kinase 2 gene mutations. Neuromuscul Disord 19:784–787.
   PubMedGoogle Scholar
• Copeland WC. 2008. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 59:131–146.
   PubMed Web of Science ®Google Scholar
• De Vries MC, Rodenburg RJ, Morava E, van Kaauwen EP, ter Laak H, Mullaart RA, Snoeck IN, van Hasselt PM, Harding P, van den Heuvel LP, Smeitink JA. 2007. Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations. Eur J Pediatr 166:229–234.
   PubMedGoogle Scholar
• Dimmock DP, Zhang Q, Dionisi-Vici C, Carrozzo R, Shieh J, Tang LY, Truong C, Schmitt E, Sifry-Platt M, Lucioli S, Santorelli FM, Ficicioglu CH, Rodriguez M, Wierenga K, Enns GM, Longo N, Lipson MH, Vallance H, Craigen WJ, Scaglia F, Wong LJ. 2008. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 29:330–331.
   PubMedGoogle Scholar
• Eriksson S, Wang L. 2008. Molecular mechanisms of mitochondrial DNA depletion diseases caused by deficiencies in enzymes in purine and pyrimidine metabolism. Nucleosides Nucleotides Nucleic Acids 27:800–808.
   PubMed Web of Science ®Google Scholar
• Falkenberg M, Larsson NG, Gustafsson CM. 2007. DNA replication and transcription in mammalian mitochondria. Annu Rev Biochem 76:679–699.
   PubMed Web of Science ®Google Scholar
• Ferrari G, Lamantea E, Donati A, Filosto M, Briem E, Carrara F, Parini R, Simonati A, Santer R, Zeviani M. 2005. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA. Brain 128:723–731.
   PubMedGoogle Scholar
• Fratter C, Gorman GS, Stewart JD, Buddles M, Smith C, Evans J, Seller A, Poulton J, Roberts M, Hanna MG, Rahman S, Omer SE, Klopstock T, Schoser B, Kornblum C, Czermin B, Lecky B, Blakely EL, Craig K, Chinnery PF, Turnbull DM, Horvath R, Taylor RW. 2010. The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology 74:1619–1626.
   PubMedGoogle Scholar
• Fratter C, Raman P, Alston CL, Blakely EL, Craig K, Smith C, Evans J, Seller A, Czermin B, Hanna MG, Poulton J, Brierley C, Staunton TG, Turnpenny PD, Schaefer AM, Chinnery PF, Horvath R, Turnbull DM, Gorman GS, Taylor RW. 2011. RRM2B mutations are frequent in familial PEO with multiple mtDNA deletions. Neurology 76:2032–2034.
   PubMedGoogle Scholar
• Freisinger P, Fütterer N, Lankes E, Gempel K, Berger TM, Spalinger J, Hoerbe A, Schwantes C, Lindner M, Santer R, Burdelski M, Schaefer H, Setzer B, Walker UA, Horváth R. 2006. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol 63:1129–1134.
   PubMedGoogle Scholar
• Galbiati S, Bordoni A, Papadimitriou D, Toscano A, Rodolico C, Katsarou E, Sciacco M, Garufi A, Prelle A, Aguennouz M, Bonsignore M, Crimi M, Martinuzzi A, Bresolin N, Papadimitriou A, Comi GP. 2006. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 34:177–185.
   PubMed Web of Science ®Google Scholar
• Gandhi VV, Samuels DC. 2011. Enzyme kinetics of the mitochondrial deoxyribonucleoside salvage pathway are not sufficient to support rapid mtDNA replication. PLoS Comput Biol 7: e1002078.
   PubMedGoogle Scholar
• Garrido N, Griparic L, Jokitalo E, Wartiovaara J, van der Bliek AM, Spelbrink JN. 2003. Composition and dynamics of human mitochondrial nucleoids. Mol Biol Cell 14:1583–1596.
   PubMed Web of Science ®Google Scholar
• Goffart S, Cooper HM, Tyynismaa H, Wanrooij S, Suomalainen A, Spelbrink JN. 2009. Twinkle mutations associated with autosomal dominant progressive external ophthalmoplegia lead to impaired helicase function and in vivo mtDNA replication stalling. Hum Mol Genet 18:328–340.
   PubMed Web of Science ®Google Scholar
• Götz A, Isohanni P, Pihko H, Paetau A, Herva R, Saarenpää-Heikkilä O, Valanne L, Marjavaara S, Suomalainen A. 2008. Thymidine kinase 2 defects can cause multi-tissue mtDNA depletion syndrome. Brain 131:2841–2850.
   PubMed Web of Science ®Google Scholar
• Graziewicz MA, Longley MJ, Bienstock RJ, Zeviani M, Copeland WC. 2004. Structure-function defects of human mitochondrial DNA polymerase in autosomal dominant progressive external ophthalmoplegia. Nat Struct Mol Biol 11:770–776.
   PubMedGoogle Scholar
• Graziewicz MA, Longley MJ, Copeland WC. 2006. DNA polymerase gamma in mitochondrial DNA replication and repair. Chem Rev 106:383–405.
   PubMed Web of Science ®Google Scholar
• Hakonen AH, Heiskanen S, Juvonen V, Lappalainen I, Luoma PT, Rantamaki M, Goethem GV, Lofgren A, Hackman P, Paetau A, Kaakkola S, Majamaa K, Varilo T, Udd B, Kaariainen H, Bindoff LA, Suomalainen A. 2005. Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin. Am J Hum Genet 77:430–441.
   PubMed Web of Science ®Google Scholar
• Hakonen AH, Isohanni P, Paetau A, Herva R, Suomalainen A, Lönnqvist T. 2007. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130:3032–3040.
   PubMedGoogle Scholar
• Hirano M, Lagier-Tourenne C, Valentino ML, Martí R, Nishigaki Y. 2005. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 354:152–156.
   PubMedGoogle Scholar
• Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG. 2006. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460.
   PubMed Web of Science ®Google Scholar
• Hirano M, Marti R, Ferreiro-Barros C, Vilà MR, Tadesse S, Nishigaki Y, Nishino I, Vu TH. 2001. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Dev Biol 12:417–427.
   PubMedGoogle Scholar
• Hirano M, Nishigaki Y, Martí R. 2004. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10:8–17.
   PubMed Web of Science ®Google Scholar
• Holmlund T, Farge G, Pande V, Korhonen J, Nilsson L, Falkenberg M. 2009. Structure-function defects of the twinkle amino-terminal region in progressive external ophthalmoplegia. Biochim Biophys Acta 1792:132–139.
   PubMed Web of Science ®Google Scholar
• Horvath R, Hudson G, Ferrari G, Fütterer N, Ahola S, Lamantea E, Prokisch H, Lochmüller H, McFarland R, Ramesh V, Klopstock T, Freisinger P, Salvi F, Mayr JA, Santer R, Tesarova M, Zeman J, Udd B, Taylor RW, Turnbull D, Hanna M, Fialho D, Suomalainen A, Zeviani M, Chinnery PF. 2006. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674–1684.
   PubMedGoogle Scholar
• Hudson G, Chinnery PF. 2006. Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 15 Spec No 2:R244–R252.
   Google Scholar
• Hudson G, Deschauer M, Busse K, Zierz S, Chinnery PF. 2005. Sensory ataxic neuropathy due to a novel C10Orf2 mutation with probable germline mosaicism. Neurology 64:371–373.
   PubMed Web of Science ®Google Scholar
• Hudson G, Deschauer M, Taylor RW, Hanna MG, Fialho D, Schaefer AM, He LP, Blakely E, Turnbull DM, Chinnery PF. 2006. POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Neurology 66:1439–1441.
   PubMedGoogle Scholar
• Kaguni LS. 2004. DNA polymerase gamma, the mitochondrial replicase. Annu Rev Biochem 73:293–320.
   PubMed Web of Science ®Google Scholar
• Kasiviswanathan R, Longley MJ, Chan SS, Copeland WC. 2009. Disease mutations in the human mitochondrial DNA polymerase thumb subdomain impart severe defects in mitochondrial DNA replication. J Biol Chem 284:19501–19510.
   PubMed Web of Science ®Google Scholar
• Korhonen JA, Pande V, Holmlund T, Farge G, Pham XH, Nilsson L, Falkenberg M. 2008. Structure-function defects of the TWINKLE linker region in progressive external ophthalmoplegia. J Mol Biol 377:691–705.
   PubMed Web of Science ®Google Scholar
• Korhonen JA, Pham XH, Pellegrini M, Falkenberg M. 2004. Reconstitution of a minimal mtDNA replisome in vitro. EMBO J 23:2423–2429.
   PubMed Web of Science ®Google Scholar
• Kukat C, Wurm CA, Spåhr H, Falkenberg M, Larsson NG, Jakobs S. 2011. Super-resolution microscopy reveals that mammalian mitochondrial nucleoids have a uniform size and frequently contain a single copy of mtDNA. Proc Natl Acad Sci USA 108:13534–13539.
   PubMed Web of Science ®Google Scholar
• Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu AL, Valentino ML, Anikster Y, Hirano M, Martí R. 2006. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 67:1461–1463.
   PubMed Web of Science ®Google Scholar
• Lesko N, Naess K, Wibom R, Solaroli N, Nennesmo I, von Döbeln U, Karlsson A, Larsson NG. 2010. Two novel mutations in thymidine kinase-2 cause early onset fatal encephalomyopathy and severe mtDNA depletion. Neuromuscul Disord 20:198–203.
   PubMedGoogle Scholar
• Lewis W, Day BJ, Kohler JJ, Hosseini SH, Chan SS, Green EC, Haase CP, Keebaugh ES, Long R, Ludaway T, Russ R, Steltzer J, Tioleco N, Santoianni R, Copeland WC. 2007. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma. Lab Invest 87:326–335.
   PubMed Web of Science ®Google Scholar
• Lim SE, Copeland WC. 2001. Differential incorporation and removal of antiviral deoxynucleotides by human DNA polymerase gamma. J Biol Chem 276:23616–23623.
   PubMed Web of Science ®Google Scholar
• Lim SE, Longley MJ, Copeland WC. 1999. The mitochondrial p55 accessory subunit of human DNA polymerase gamma enhances DNA binding, promotes processive DNA synthesis, and confers N-ethylmaleimide resistance. J Biol Chem 274:38197–38203.
   PubMedGoogle Scholar
• Longley MJ, Clark S, Yu Wai Man C, Hudson G, Durham SE, Taylor RW, Nightingale S, Turnbull DM, Copeland WC, Chinnery PF. 2006. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 78:1026–1034.
   PubMed Web of Science ®Google Scholar
• Longley MJ, Graziewicz MA, Bienstock RJ, Copeland WC. 2005. Consequences of mutations in human DNA polymerase gamma. Gene 354:125–131.
   PubMed Web of Science ®Google Scholar
• Longley MJ, Humble MM, Sharief FS, Copeland WC. 2010. Disease variants of the human mitochondrial DNA helicase encoded by C10orf2 differentially alter protein stability, nucleotide hydrolysis, and helicase activity. J Biol Chem 285:29690–29702.
   PubMed Web of Science ®Google Scholar
• Longley MJ, Nguyen D, Kunkel TA, Copeland WC. 2001. The fidelity of human DNA polymerase gamma with and without exonucleolytic proofreading and the p55 accessory subunit. J Biol Chem 276:38555–38562.
   PubMed Web of Science ®Google Scholar
• Lönnqvist T, Paetau A, Valanne L, Pihko H. 2009. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 132:1553–1562.
   PubMedGoogle Scholar
• Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, Oldfors A, Rautakorpi I, Peltonen L, Majamaa K, Somer H, Suomalainen A. 2004. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364:875–882.
   PubMed Web of Science ®Google Scholar
• Luoma PT, Luo N, Löscher WN, Farr CL, Horvath R, Wanschitz J, Kiechl S, Kaguni LS, Suomalainen A. 2005. Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome. Hum Mol Genet 14:1907–1920.
   PubMedGoogle Scholar
• Mancuso M, Filosto M, Bonilla E, Hirano M, Shanske S, Vu TH, DiMauro S. 2003. Mitochondrial myopathy of childhood associated with mitochondrial DNA depletion and a homozygous mutation (T77M) in the TK2 gene. Arch Neurol 60:1007–1009.
   PubMedGoogle Scholar
• Mancuso M, Salviati L, Sacconi S, Otaegui D, Camaño P, Marina A, Bacman S, Moraes CT, Carlo JR, Garcia M, Garcia-Alvarez M, Monzon L, Naini AB, Hirano M, Bonilla E, Taratuto AL, DiMauro S, Vu TH. 2002. Mitochondrial DNA depletion: mutations in thymidine kinase gene with myopathy and SMA. Neurology 59:1197–1202.
   PubMed Web of Science ®Google Scholar
• Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N. 2001. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341.
   PubMed Web of Science ®Google Scholar
• Martí R, Nishigaki Y, Hirano M. 2003. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 303:14–18.
   PubMed Web of Science ®Google Scholar
• Matsushima Y, Kaguni LS. 2007. Differential phenotypes of active site and human autosomal dominant progressive external ophthalmoplegia mutations in Drosophila mitochondrial DNA helicase expressed in Schneider cells. J Biol Chem 282:9436–9444.
   PubMed Web of Science ®Google Scholar
• Miller FJ, Rosenfeldt FL, Zhang C, Linnane AW, Nagley P. 2003. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. Nucleic Acids Res 31:e61.
   PubMed Web of Science ®Google Scholar
• Mousson De Camaret B, Taanman JW, Padet S, Chassagne M, Mayencon M, Clerc-Renaud P, Mandon G, Zabot MT, Lachaux A, Bozon D. 2007 Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem J 402:377–385.
   PubMed Web of Science ®Google Scholar
• Naviaux RK, Nguyen KV. 2004. POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 55:706–712.
   PubMed Web of Science ®Google Scholar
• Naviaux RK, Nyhan WL, Barshop BA, Poulton J, Markusic D, Karpinski NC, Haas RH. 1999. Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers’ syndrome. Ann Neurol 45:54–58.
   PubMed Web of Science ®Google Scholar
• Nguyen KV, Sharief FS, Chan SS, Copeland WC, Naviaux RK. 2006. Molecular diagnosis of Alpers syndrome. J Hepatol 45:108–116.
   PubMed Web of Science ®Google Scholar
• Nishigaki Y, Martí R, Copeland WC, Hirano M. 2003. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111:1913–1921.
   PubMed Web of Science ®Google Scholar
• Nishino I, Spinazzola A, Hirano M. 1999. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689–692.
   PubMed Web of Science ®Google Scholar
• Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, Connolly AM, Verloes A, Guimarães J, Maillard I, Hamano H, Donati MA, Semrad CE, Russell JA, Andreu AL, Hadjigeorgiou GM, Vu TH, Tadesse S, Nygaard TG, Nonaka I, Hirano I, Bonilla E, Rowland LP, DiMauro S, Hirano M. 2000. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol 47:792–800.
   PubMed Web of Science ®Google Scholar
• Pagnamenta AT, Taanman JW, Wilson CJ, Anderson NE, Marotta R, Duncan AJ, Bitner-Glindzicz M, Taylor RW, Laskowski A, Thorburn DR, Rahman S. 2006. Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma. Hum Reprod 21:2467–2473.
   PubMed Web of Science ®Google Scholar
• Ponamarev MV, Longley MJ, Nguyen D, Kunkel TA, Copeland WC. 2002. Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J Biol Chem 277:15225–15228.
   PubMedGoogle Scholar
• Saada A, Shaag A, Elpeleg O. 2003. mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency. Mol Genet Metab 79:1–5.
   PubMed Web of Science ®Google Scholar
• Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. 2001. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 29:342–344.
   PubMed Web of Science ®Google Scholar
• Salviati L, Sacconi S, Mancuso M, Otaegui D, Camaño P, Marina A, Rabinowitz S, Shiffman R, Thompson K, Wilson CM, Feigenbaum A, Naini AB, Hirano M, Bonilla E, DiMauro S, Vu TH. 2002. Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 52:311–317.
   PubMed Web of Science ®Google Scholar
• Saneto RP, Naviaux RK. 2010. Polymerase gamma disease through the ages. Dev Disabil Res Rev 16:163–174.
   PubMed Web of Science ®Google Scholar
• Scaglia F, Dimmock D, Wong LJ. 2009. DGUOK-Related Mitochondrial DNA Depletion Syndrome, Hepatocerebral Form. GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Copyright, University of Washington, Seattle, 1997-2010. Available at: http://www.genetests.org. Accessed on 15 August 2011.
   Google Scholar
• Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Wong LJ, Shinawi M. 2009. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 66:1028–1032.
   PubMedGoogle Scholar
• Song S, Wheeler LJ, Mathews CK. 2003. Deoxyribonucleotide pool imbalance stimulates deletions in HeLa cell mitochondrial DNA. J Biol Chem 278:43893–43896.
   PubMed Web of Science ®Google Scholar
• Spelbrink JN, Li FY, Tiranti V, Nikali K, Yuan QP, Tariq M, Wanrooij S, Garrido N, Comi G, Morandi L, Santoro L, Toscano A, Fabrizi GM, Somer H, Croxen R, Beeson D, Poulton J, Suomalainen A, Jacobs HT, Zeviani M, Larsson C. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:223–231.
   PubMed Web of Science ®Google Scholar
• Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M. 2002. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4133.
   PubMed Web of Science ®Google Scholar
• Spinazzola A, Marti R, Nishino I, Andreu AL, Naini A, Tadesse S, Pela I, Zammarchi E, Donati MA, Oliver JA, Hirano M. 2002. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 277:4128–4133.
   PubMed Web of Science ®Google Scholar
• Stuart GR, Santos JH, Strand MK, Van Houten B, Copeland WC. 2006. Mitochondrial and nuclear DNA defects in Saccharomyces cerevisiae with mutations in DNA polymerase gamma associated with progressive external ophthalmoplegia. Hum Mol Genet 15:363–374.
   PubMedGoogle Scholar
• Stumpf JD, Bailey CM, Spell D, Stillwagon M, Anderson KS, Copeland WC. 2010. mip1 containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in Saccharomyces cerevisiae. Hum Mol Genet 19:2123–2133.
   PubMedGoogle Scholar
• Szczepanowska K, Foury F. 2010. A cluster of pathogenic mutations in the 3′-5′ exonuclease domain of DNA polymerase gamma defines a novel module coupling DNA synthesis and degradation. Hum Mol Genet 19:3516–3529.
   PubMedGoogle Scholar
• Tang S, Wang J, Lee NC, Milone M, Halberg MC, Schmitt ES, Craigen WJ, Zhang W, Wong LJ. 2011. Mitochondrial DNA polymerase {gamma} mutations: an ever expanding molecular and clinical spectrum. J Med Genet 48:669–681.
   PubMed Web of Science ®Google Scholar
• Torres-Torronteras J, Gómez A, Eixarch H, Palenzuela L, Pizzorno G, Hirano M, Andreu AL, Barquinero J, Martí R. 2011. Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 18:795–806.
   PubMed Web of Science ®Google Scholar
• Tyynismaa H, Mjosund KP, Wanrooij S, Lappalainen I, Ylikallio E, Jalanko A, Spelbrink JN, Paetau A, Suomalainen A. 2005. Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci USA 102:17687–17692.
   PubMed Web of Science ®Google Scholar
• Tyynismaa H, Suomalainen A. 2009. Mouse models of mitochondrial DNA defects and their relevance for human disease. EMBO Rep 10:137–143.
   PubMed Web of Science ®Google Scholar
• Tyynismaa H, Ylikallio E, Patel M, Molnar MJ, Haller RG, Suomalainen A. 2009. A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am J Hum Genet 85:290–295.
   PubMedGoogle Scholar
• Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, Ferrari G, Aarseth JH, Bindoff LA. 2006. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692.
   PubMed Web of Science ®Google Scholar
• Valentino ML, Martí R, Tadesse S, López LC, Manes JL, Lyzak J, Hahn A, Carelli V, Hirano M. 2007. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS Lett 581:3410–3414.
   PubMed Web of Science ®Google Scholar
• Van Goethem G, Dermaut B, Löfgren A, Martin JJ, Van Broeckhoven C. 2001. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211–212.
   PubMed Web of Science ®Google Scholar
• Van Goethem G, Luoma P, Rantamäki M, Al Memar A, Kaakkola S, Hackman P, Krahe R, Löfgren A, Martin JJ, De Jonghe P, Suomalainen A, Udd B, Van Broeckhoven C. 2004. POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology 63:1251–1257.
   PubMed Web of Science ®Google Scholar
• Van Goethem G, Martin JJ, Dermaut B, Löfgren A, Wibail A, Ververken D, Tack P, Dehaene I, Van Zandijcke M, Moonen M, Ceuterick C, De Jonghe P, Van Broeckhoven C. 2003. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13:133–142.
   PubMed Web of Science ®Google Scholar
• Van Hove JL, Cunningham V, Rice C, Ringel SP, Zhang Q, Chou PC, Truong CK, Wong LJ. 2009. Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease. Am J Med Genet A 149A:861–867.
   PubMedGoogle Scholar
• Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482–1488.
   PubMed Web of Science ®Google Scholar
• Walter MC, Czermin B, Muller-Ziermann S, Bulst S, Stewart JD, Hudson G, Schneiderat P, Abicht A, Holinski-Feder E, Lochmüller H, Chinnery PF, Klopstock T, Horvath R. 2010. Late-onset ptosis and myopathy in a patient with a heterozygous insertion in POLG2. J Neurol 257:1517–1523.
   PubMed Web of Science ®Google Scholar
• Wang L, Eriksson S. 2003. Mitochondrial deoxyguanosine kinase mutations and mitochondrial DNA depletion syndrome. FEBS Lett 554:319–322.
   PubMed Web of Science ®Google Scholar
• Wang L, Limongelli A, Vila MR, Carrara F, Zeviani M, Eriksson S. 2005. Molecular insight into mitochondrial DNA depletion syndrome in two patients with novel mutations in the deoxyguanosine kinase and thymidine kinase 2 genes. Mol Genet Metab 84:75–82.
   PubMed Web of Science ®Google Scholar
• Wang L, Saada A, Eriksson S. 2003. Kinetic properties of mutant human thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J Biol Chem 278:6963–6968.
   PubMed Web of Science ®Google Scholar
• Wanrooij S, Goffart S, Pohjoismäki JL, Yasukawa T, Spelbrink JN. 2007. Expression of catalytic mutants of the mtDNA helicase Twinkle and polymerase POLG causes distinct replication stalling phenotypes. Nucleic Acids Res 35:3238–3251.
   PubMed Web of Science ®Google Scholar
• Winterthun S, Ferrari G, He L, Taylor RW, Zeviani M, Turnbull DM, Engelsen BA, Moen G, Bindoff LA. 2005. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 64:1204–1208.
   PubMedGoogle Scholar
• Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, Milone M, Cohen BH, Wical B, Ganesh J, Basinger AA, Burton BK, Swoboda K, Gilbert DL, Vanderver A, Saneto RP, Maranda B, Arnold G, Abdenur JE, Waters PJ, Copeland WC. 2008. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150–E172.
   Google Scholar
• Young MJ, Longley MJ, Li FY, Kasiviswanathan R, Wong LJ, Copeland WC. 2011. Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet 20:3052–3066.
   PubMedGoogle Scholar
• Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. 1989. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 339:309–311.
   PubMed Web of Science ®Google Scholar